Consumer Health & Nutrition

Therapies & Markets

PharmaVision's Therapies and Market reports provide comprehensive coverage of major therapeutic markets in the developed and emerging economies. Each report assesses the competitive landscape and analyzes key market trends, therapeutic developments and market leaders. The reports provide detailed market analysis and forecasts for products and/or technologies in anti-infectives, autoimmune & inflammatory, cardiovascular, central nervous system, metabolic & gastrointestinal, respiratory and vaccines in the US, Europe, Japan and the emerging markets.

Therapies & Markets Research Reports

Global Pharmaceuticals

Published: 17/01/2012

DM GPI 0111

GlaxoSmithKline Case Study: Through mergers and acquisitions to success

Published: 31/12/2011

DMGSK 1211

Johnson & Johnson Case Study: Remicade, a biotech blockbuster

Published: 31/12/2011

DNJ&J 1211

ALK-Abello AS

Published: 22/12/2011

DM ALK 0611

STADA Arzneimittel

Published: 22/12/2011

DMSTADA 1211

ViroPharma, Inc

Published: 21/12/2011

DM VIRO 0611

Marina Biotech, Inc.

Published: 20/12/2011

DMMARBIO 0611

Celgene Corporation

Published: 04/11/2011

DMCEL 1111

Amylin Pharmaceuticals

Published: 04/11/2011

DM AmP 0611

Biotechnology: Global Industry Guide

Published: 30/09/2011

DM BGIG 0911

Health Care Equipment & Supplies: Global Industry Guide

Published: 31/08/2011

DM HCES 0811

Global Health Care Supplies

Published: 09/08/2011

DM GHCS 0811

Pharmaceuticals in China:Industry and Country Analysis

Published: 30/07/2011

DM CICA 0711

Pharmaceuticals in South Korea – Industry and Country Analysis

Published: 30/07/2011

DM SKICA 0711

Acorda Therapeutics, Inc.

Published: 14/06/2011

DM AT 0611

CSL Ltd

Published: 14/06/2011

DM CSL 0611

Cubist Pharmaceuticals, Inc

Published: 14/06/2011

DM CubP 0611

InterMune, Inc.

Published: 14/06/2011

DM INM 0611

Teva Pharmaceutical Industries Ltd

Published: 14/06/2011

DM TEVA 0611

Santarus, Inc.

Published: 14/06/2011

DM SAN 0611

Novavax, Inc.

Published: 13/06/2011

DM NOV 0611

Enzon Pharmaceuticals, Inc.

Published: 10/06/2011

DM ENZO 0611

Ranbaxy Laboratories Limited

Published: 08/06/2011

Cipla Ltd

Published: 07/06/2011

DM Cip 0611

Crucell N.V.

Published: 06/06/2011

DM Cru 0611

Ophthalmology Drug Futures

Published: 12/04/2011

ESP OPTHAL DF 04/11

Orphan Drugs: Strategic Approaches for the Industry

Published: 31/03/2011

ESP ORPHAN 03/11

Gastric Cancer Drug Discoveries: What the future holds

Published: 31/03/2011

ESP GC 03/11

Global: Pharmaceuticals Industry Guide

Published: 28/03/2011

DM GPIG 0311

Will Anyone Crack the Obesity Drug Market?

Published: 14/02/2011

ESP OBESITY 02/11

Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide

Published: 31/01/2011

DM PBRIC 011

Pharmaceuticals-Top 5 Emerging Markets Industry Guide

Published: 03/01/2011

DM EMIG 0111

Cancer Drug Blockbusters

Published: 04/11/2010

ESP CAN BB 11/10

OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide

Published: 01/11/2010

DM OTC5 1110

OTC Pharmaceuticals: Global Industry Guide

Published: 01/11/2010

DM OTCG 1110

Multiple Sclerosis Drug Discoveries: What the future holds

Published: 19/10/2010

ESP MS 10/10

Global Biotechnology

Published: 02/08/2010

Lung Cancer: Global Incidence, Prevalence and Mortality to 2015

Published: 07/07/2010

ESP LC 07/10

Global Pharmaceuticals, Biotechnology & Life Sciences

Published: 01/06/2010

DM GPBLS 0610

New Drug Futures: Products that could change the pharma market to 2010 & beyond

Published: 21/04/2009

ESP NEW DF 04/09

CNS Drug Discoveries: What the future holds

Published: 27/11/2006

ESP CNS DDIS 11/06